Collaborative Arrangement, Future Cash Payments

No definition available.

Name:	tars_CollaborativeArrangementFutureCashPayments
Namespace Prefix:	tars_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Maximum Milestone Payment

+ References

No definition available.

+ Details

Name:	tars_CollaborativeArrangementMaximumMilestonePayment
Namespace Prefix:	tars_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales

+ References

No definition available.

+ Details

Name:	tars_CollaborativeArrangementRightsAndObligationsContractualMilestoneNetSales
Namespace Prefix:	tars_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaborative Arrangement, Rights And Obligations, Upfront Payment

+ References

No definition available.

+ Details

Name:	tars_CollaborativeArrangementRightsAndObligationsUpfrontPayment
Namespace Prefix:	tars_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_ProductOrServiceAxis=tars_ClinicalMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=tars_CommercialSalesMilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=tars_CommercialAndSalesMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=tars_AnteriorInLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=tars_ElancoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=tars_SalesBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

COMMITMENTS & CONTINGENCIES - In-License Agreements (Details) - USD ($) $ in Millions	1 Months Ended						3 Months Ended		6 Months Ended		31 Months Ended
	Feb. 28, 2026	Oct. 31, 2024	Sep. 30, 2024	Aug. 31, 2023	Dec. 31, 2022	Jan. 31, 2019	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Mar. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment received		$ 2.5
Clinical Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales									$ 3.0
Commercial Sales Milestone Payments
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales									102.0
License Agreement \| Commercial and Sales Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Maximum milestone payments							$ 77.0		77.0
Anterior In-License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment received	$ 2.0
Anterior In-License Agreement \| Clinical Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales	2.5
Anterior In-License Agreement \| Commercial Sales Milestone Payments
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Maximum milestone payments	$ 92.0
Elanco \| Sales-based Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales			$ 100.0
Elanco \| License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment received						$ 1.0
Future cash payments							2.0		2.0
Maximum milestone payments							70.0		70.0
Royalty expense							9.4	$ 5.1	16.7	$ 9.0
Elanco \| License Agreement \| Clinical Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales					$ 0.5						$ 4.0
Elanco \| License Agreement \| Commercial and Sales Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales				$ 4.0
Elanco \| License Agreement \| Sales-based Milestones
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual milestone payment net sales			$ 5.0
Maximum milestone payments							$ 4.0		$ 4.0